Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Total 13F shares
-
1,946,125
-
Share change
-
+1,634,132
-
Total reported value
-
$3,774,000
-
Price per share
-
$1.94
-
Number of holders
-
12
-
Value change
-
+$3,070,716
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q4 2021
As of 31 Dec 2021,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,946,125 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, AIGH Capital Management LLC, Bleichroeder LP, VANGUARD GROUP INC, Worth Venture Partners, LLC, Eidelman Virant Capital, DRIVE WEALTH MANAGEMENT, LLC, Intersect Capital LLC, Aristides Capital LLC, and NORTHERN TRUST CORP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.